Impact of Helicobacter pylori on multiple sclerosis-related clinically isolated syndrome

Acta Neurologica Scandinavica

Volumn 133, Issue 4, 2016, Pages 268-275

  Deretzi, G ^a   Gavalas, E ^b   Boziki, M ^c   Tsiptsios, D ^a   Polyzos, S A ^b   Venizelos, I ^b   Zavos, C ^b   Koutlas, E ^a   Tsiptsios, I ^a   Katsinelos, P ^b   Kountouras, J ^b  

^a PAPAGEORGIOU GENERAL HOSPITAL   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c AHEPA UNIVERSITY HOSPITAL   (Greece)

Author keywords

Helicobacter pylori; Clinically isolated syndrome; Histological analysis; HLA alleles; Multiple sclerosis; Proinflammatory cytokines

Indexed keywords

CYANOCOBALAMIN; CYTOKINE; FOLIC ACID; GAMMA INTERFERON; HLA A ANTIGEN; HLA B ANTIGEN; HLA B57 ANTIGEN; HLA DR ANTIGEN; HOMOCYSTEINE; IMMUNOGLOBULIN G; INTERLEUKIN DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; HLA-A*26 ANTIGEN; HLA-A*30 ANTIGEN; HLA-B57 ANTIGEN;

ADULT; ARTICLE; BACTERIAL CLEARANCE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMYELINATING DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; ERADICATION THERAPY; EXPANDED DISABILITY STATUS SCALE; FEMALE; FOLLOW UP; GENETIC POLYMORPHISM; HELICOBACTER INFECTION; HISTOLOGY; HLA SYSTEM; HUMAN; MALE; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT; PILOT STUDY; PREVALENCE; BLOOD; CASE CONTROL STUDY; DEMYELINATING DISEASES; GREECE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; IMMUNOLOGY; MIDDLE AGED;

ADULT; CASE-CONTROL STUDIES; DEMYELINATING DISEASES; FEMALE; GREECE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HLA-A ANTIGENS; HLA-B ANTIGENS; HUMANS; MALE; MIDDLE AGED; PREVALENCE;

EID: 84959502278     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/ane.12453     Document Type: Article

References (47)

1. Miller DH, Chard DT, Ciccarelli O. Clinically isolated syndromes. Lancet Neurol 2012;11:157-69.
2. Montalban X, Tintore M, Swanton J et al. MRI criteria for MS in patients with clinically isolated syndromes. Neurology 2010;74:427-34.
3. Tzartos JS, Khan G, Vossenkamper A et al. Association of innate immune activation with latent Epstein-Barr virus in active MS lesions. Neurology 2012;78:15-23.
4. Franceschi F, Zuccalà G, Roccarina D, Gasbarrini A. Clinical effects of Helicobacter pylori outside the stomach. Nat Rev Gastroenterol Hepatol 2014;11:234-42.
5. Deretzi G, Kountouras J, Polyzos SA et al. Gastrointestinal immune system and brain dialogue implicated in neuroinflammatory and neurodegenerative diseases. Curr Mol Med 2011;11:696-707.
6. Wu Y, Tao Z, Song C et al. Overexpression of YKL-40 predicts plaque instability in carotid atherosclerosis with CagA-positive Helicobacter pylori infection. PLoS One 2013;8:e59996.
7. Kountouras J, Tsolaki M, Gavalas E et al. Relationship between Helicobacter pylori infection and Alzheimer disease. Neurology 2006;66:938-40.
8. Kountouras J, Tsolaki M, Boziki M et al. Association between Helicobacter pylori infection and mild cognitive impairment. Eur J Neurol 2007;14:976-82.
9. Nielsen HH, Qiu J, Friis S, Wermuth L, Ritz B. Treatment for Helicobacter pylori infection and risk of Parkinson's disease in Denmark. Eur J Neurol 2012;19:864-9.
10. Deretzi G, Kountouras J, Gavalas E et al. Multiple sclerosis and seizures: possible role of Helicobacter pylori. Eur J Neurol 2011;18:116.
11. Kountouras J. Helicobacter pylori: an intruder involved in conspiring glaucomatous neuropathy. Br J Ophthalmol 2009;93:1413-5.
12. Li W, Minohara M, Su JJ et al. Helicobacter pylori infection is a potential protective factor against conventional multiple sclerosis in the Japanese population. J Neuroimmunol 2007;184:227-31.
13. Wender M. Prevalence of Helicobacter pylori infection among patients with multiple sclerosis [Article in Polish]. Neurol Neurochir Pol 2003;37:45-8.
14. Long Y, Gao C, Qiu W et al. Helicobacter pylori infection in neuromyelitis optica and multiple sclerosis. Neuroimmunomodulation 2013;20:107-12.
15. Mohebi N, Mamarabadi M, Moghaddasi M. Relation of helicobacter pylori infection and multiple sclerosis in Iranian patients. Neurol Int 2013;25:31-3.
16. Ram M, Barzilai O, Shapira Y et al. Helicobacter pylori serology in autoimmune diseases - fact or fiction? Clin Chem Lab Med 2013;51:1075-82.
17. Gavalas E, Kountouras J, Deretzi G et al. Helicobacter pylori and multiple sclerosis. J Neuroimmunol 2007;188:187-9.
18. Gavalas E, Kountouras J, Boziki M et al. Relationship between Helicobacter pylori infection and multiple sclerosis. Ann Gastroenterol 2015;28:351-4.
19. Kountouras J, Zavos C, Gavalas E, Boziki M, Katsinelos P. Helicobacter pylori may hold a variable role in multiple sclerosis based on ethnicity. Med Hypotheses 2008;71:614-5.
20. Kountouras J, Mylopoulos N, Chatzopoulos D et al. Eradication of Helicobacter pylori may be beneficial in the management of chronic open angle glaucoma. Arch Intern Med 2002;162:1237-44.
21. Disanto G, Morahan JM, Barnett MH, Giovannoni G, Ramagopalan SV. The evidence for a role of B cells in multiple sclerosis. Neurology 2012;78:823-32.
22. Kountouras J, Zavos C, Chatzopoulos D. Helicobacter pylori and glaucoma. Ophthalmology 2003;110:2433-4.
23. Wong F, Rayner-Hartley E, Byrne MF. Extraintestinal manifestations of Helicobacter pylori: a concise review. World J Gastroenterol 2014;20:11950-61.
24. Deretzi G, Kountouras J, Polyzos SA et al. Polyautoimmunity in a Greek cohort of multiple sclerosis. Acta Neurol Scand 2015;131:225-30.
25. Nagata A, Sekiguchi N, Kurimoto M, Noto S, Takezako N. Significance of lymphocyte counts at diagnosis in the management of ITP: the relationship between lymphocyte counts and treatment success in H. pylori-infected patients. Int J Hematol 2015;101:268-72.
26. Rocha AM, Souza C, Melo FF et al. Cytokine profile of patients with chronic immune thrombocytopenia affects platelet count recovery after Helicobacter pylori eradication. Br J Haematol 2015;168:421-8.
27. Romme Christensen J, Börnsen L, Hesse D et al. Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis. J Neuroinflammation 2012;9:215.
28. Minty A, Chalon P, Dumont X et al. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993;362:248-50.
29. Togawa S, Joh T, Itoh M et al. Interleukin-2 gene polymorphisms associated with increased risk of gastric atrophy from Helicobacter pylori infection. Helicobacter 2005;10:172-8.
30. Eskandari-Nasab E, Sepanjnia A, Moghadampour M et al. Circulating levels of interleukin (IL)-12 and IL-13 in Helicobacter pylori-infected patients, and their associations with bacterial CagA and VacA virulence factors. Scand J Infect Dis 2013;45:342-9.
31. Becker Y. Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy-a review. Virus Genes 2006;33:235-52.
32. Na KS, Jung HY, Kim YK. The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2014;48:277-86.
33. Orbach R, Gurevich M, Achiron A. Interleukin-12p40 in the spinal fluid as a biomarker for clinically isolated syndrome. Mult Scler 2014;20:35-42.
34. Marotti B, Rocco A, de Colibus P et al. Interleukin-13 mucosal production in Helicobacter pylori-related gastric diseases. Dig Liver Dis 2008;40:240-7.
35. Sospedra M, Martin R. Immunology of multiple sclerosis. Annu Rev Immunol 2005;23:683-747.
36. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002;347:1175-86.
37. Robinson K, Kenefeck R, Pidgeon EL et al. Helicobacter pylori-induced peptic ulcer disease is associated with inadequate regulatory T cell responses. Gut 2008;57:1375-85.
38. Oliveira SH, Canetti C, Ribeiro RA, Cunha FQ. Neutrophil migration induced by IL-1beta depends upon LTB4 released by macrophages and upon TNF-alpha and IL-1beta released by mast cells. Inflammation 2008;31:36-46.
39. Figueiredo CA, Marques CR, Costa Rdos S, Da Silva HB, Alcantara-Neves NM. Cytokines, cytokine gene polymorphisms and Helicobacter pylori infection: friend or foe? World J Gastroenterol 2014;20:5235-43.
40. Kountouras J, Zavos C, Diamantidis MD et al. A concept of Helicobacter pylori and stress-secreted mast cells' potential involvement in brain metastases. J Neuroimmunol 2009;209:121-2.
41. Kountouras J, Deretzi G, Gavalas E et al. A proposed role of human defensins in Helicobacter pylori-related neurodegenerative disorders. Med Hypotheses 2014;82:368-73.
42. Dacunha AA, Ferreira AGK, Loureiro SO et al. Chronic hyperhomocysteinemia increases inflammatory markers in hippocampus and serum of rats. Neurochem Res 2012;37:1660e9.
43. Teunissen CE, Killestein J, Kragt JJ, Polman CH, Dijkstra CD, Blom HJ. Serum homocysteine levels in relation to clinical progression in multiple sclerosis. J Neurol Neurosurg Psychiatry 2008;79:1349-53.
44. Horakova D, Zivadinov R, Weinstock-Guttman B et al. Environmental factors associated with disease progression after the first demyelinating event: results from the multi-center SET study. PLoS One 2013;8:e53996.
45. Lill CM, Zipp F. The genetic profile of multiple sclerosis: risk genes and the "dark matter" [Article in German]. Nervenarzt 2012;83:705-13.
46. Link J, Kockum I, Lorentzen AR et al. Importance of human leukocyte antigen (HLA) class I and II alleles on the risk of multiple sclerosis. PLoS One 2012;7:e36779.
47. Greer JM. The role of HLA in MS susceptibility and phenotype. Curr Top Behav Neurosci 2014; PMID: 25502788. [Epub ahead of print].